2019
DOI: 10.1007/s11096-019-00944-x
|View full text |Cite
|
Sign up to set email alerts
|

The analysis of the use of potentially inappropriate medications in elderly in the Slovak Republic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(15 citation statements)
references
References 50 publications
2
11
2
Order By: Relevance
“…Cross-sectional studies in Japan have reported that patients who were prescribed by two or more physicians or who consulted more medical institutions are more likely to have PP and PIM use [8,70], as shown in our study. Furthermore, our study demonstrated that there is also a significant association between PP and PIM use, which is supported by previous reports [8,[20][21][22][23][24][25][26][27]. The frequency of elderly PIM(+) patients in Japan varies from 22.9% to 67.3% [8,22,23,27,31,35,68,71,72] because of different study populations and settings, different definitions of PIMs, or different timings of the investigation.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Cross-sectional studies in Japan have reported that patients who were prescribed by two or more physicians or who consulted more medical institutions are more likely to have PP and PIM use [8,70], as shown in our study. Furthermore, our study demonstrated that there is also a significant association between PP and PIM use, which is supported by previous reports [8,[20][21][22][23][24][25][26][27]. The frequency of elderly PIM(+) patients in Japan varies from 22.9% to 67.3% [8,22,23,27,31,35,68,71,72] because of different study populations and settings, different definitions of PIMs, or different timings of the investigation.…”
Section: Discussionsupporting
confidence: 88%
“…Potentially inappropriate medications (PIMs), defined as medications with more harmful than beneficial effects on elderly patients [19], are closely related to PP [8,[20][21][22][23][24][25][26][27] and are a relevant public health concern for elderly patients [28,29]. In 2015, the Japan Geriatric Society (JGS) updated the "Guidelines for Medical Treatment and its Safety in the Elderly" and proposed medication lists regarding PIMs, "Screening Tool for Older Persons' Appropriate Prescriptions for Japanese" (STOPP-J), to contribute to improving prescription quality [30,31].…”
Section: Introductionmentioning
confidence: 99%
“…High consumption of proton pump inhibitors is frequently observed. 15 , 44 , 48 , 49 According to a critical review 25% to 75% of the prescriptions of roton inhibitors prescription have no indication of use. 50 These drugs are used to reduce gastric acid production and are associated with an increased risk of Clostridioides difficile infections and hip fractures.…”
Section: Discussionmentioning
confidence: 99%
“…Most studies focus on older cohorts, aged 65 years or older, some studies also include middle-aged adults, while the addition of younger cohorts appears less common among general populations ( Table 2 ). Applying a ⩾5 medicine cut point, the prevalence of polypharmacy reported in the literature ranged from 7.0% up to 83.0%; 24 , 25 however, there was substantial heterogeneity across the literature in terms of study population, age group, methods for counting medicines and geographic locations ( Table 2 ). The inclusion of younger cohorts generally appears to lower the prevalence of polypharmacy across the literature; however, similar estimates were observed between an older sample of community-dwelling men (35.9%) 26 and primary care outpatients aged 20 years or older (39.2%), 27 which suggests in some cases the study context may be just as important a determinant as age ( Table 2 ).…”
Section: Polypharmacy (Overprescribing)mentioning
confidence: 99%
“…The prevalence of PIMs appears to be a widely reported statistic. Estimates range from 10.3% to 90.6%; 25 , 44 however, the tools used to measure prevalence varied across study populations ( Table 10 ). It was common for authors to acknowledge the differences between the tools by investigating more than one PIMs tool in the same study sample.…”
Section: Omitted Medicines (Underprescribing)mentioning
confidence: 99%